Position in VIR
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$2,083,648
+$827,244 QoQ
Shares Held
232,550
+11.6% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 52%
Shared 0%
None 48%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,238,289,073 across 287 Biotechnology names. VIR ranks #84 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in VIR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,083,648 | 232,550 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,256,404 | 208,359 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,295,022 | 226,799 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,153,902 | 228,949 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,468,685 | 226,649 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,737,238 | 236,681 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,763,093 | 235,393 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,122,685 | 238,504 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,316,599 | 228,687 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,771,107 | 275,458 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,454,818 | 261,987 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $6,073,946 | 247,613 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $5,477,478 | 235,388 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,586,473 | 220,722 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,287,235 | 222,367 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $5,471,108 | 214,806 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,665,858 | 64,769 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,673,566 | 63,854 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,799,815 | 64,334 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,976,323 | 62,951 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $3,095,938 | 60,385 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,752,349 | 65,435 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,098,524 | 61,128 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,819,022 | 68,807 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $361,685 | 10,554 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||